Why the study?
Is serum methylglyoxal associated with cardiovascular autonomic neuropathy and diabetic peripheral neuropathy in patients with short-term Type 2 diabetes?
Is serum methylglyoxal associated with cardiovascular autonomic neuropathy and diabetic peripheral neuropathy in patients with short-term Type 2 diabetes?
Serum methylglyoxal levels are not associated with cardiovascular autonomic or peripheral neuropathy in well-treated patients with short-term Type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Does not support methylglyoxal assessment for neuropathy in short-term T2D; leaves open its role in longer-duration disease.
Hansen et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: